1. Market Research
  2. > Biotechnology Market Trends
  3. > Aptamers Market by Type, Application, Technology & by End Users - Global Forecast to 2020

The global aptamers market is expected to reach $244.93 million by 2020 from $107.56 million in 2015, growing at a CAGR of 17.89% between 2015 and 2020. The aptamer type segments included in this report are DNA-based aptamers, RNA-based aptamers, and XNA-based aptamers. Based on applications, the report is segmented into diagnostics, therapeutics development, R&D, and other applications. Diagnostics applications will hold the largest share of the aptamers market in 2015. The therapeutics development application is expected to be one of the fastest-growing applications between 2015 and 2020.

The geographic segments included in this report are the Americas, Europe, Asia, and the Rest of the World (RoW). The geographic analysis reveals that the Americas are expected to account for the largest share in the global aptamers market in 2015. Europe is expected to register the fastest growth.

Market growth is majorly driven by the availability of R&D investments in biotechnology and pharmaceutical industries. Furthermore, the patent expiration of systematic evolution of ligands by exponential enrichment technology (SELEX), technological advancements, and the low cost and high efficiency of aptamers in binding to large molecules as compared to antibodies will aid the growth of the global aptamers market.

A combination of bottom-up and top-down approaches was used to calculate the market sizes and growth rates of the global aptamers market and its subsegments. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. Primary interviews with key opinion leaders were also used to determine the percentage shares of each subsegment and the relative differences in growth rates. The report provides qualitative insights about growth rates, and market drivers for all important subsegments. It maps market sizes and growth rates of each subsegment and identifies segments poised for rapid growth in each geographic segment. The report also includes company profiles of market leaders.

Reasons to Buy the Report:
The report will enable both established firms and new entrants to gauge the pulse of the market and help them make important strategic growth decisions.

The report provides insights on the following:
- Product Development: Product portfolios of the top players in the aptamers market.
- Competitive Assessment: In-depth assessment of the business segments and product portfolios of the leading players in the aptamers market.
- Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the market for various aptamers products across geographies.

Table Of Contents

Aptamers Market by Type, Application, Technology and by End Users - Global Forecast to 2020
TABLE OF CONTENTS

1 INTRODUCTION 14
1.1 OBJECTIVES OF THE STUDY 14
1.2 MARKET DEFINITION 14
1.2.1 MARKET COVERED 15
1.2.2 YEARS CONSIDERED IN THE REPORT 15
1.3 CURRENCY 16
1.4 STAKEHOLDERS 16
1.5 LIMITATIONS 16
2 RESEARCH METHODOLOGY 17
2.1 MARKET SIZE ESTIMATION 18
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 20
2.2.1 KEY DATA FROM SECONDARY SOURCES 21
2.2.2 KEY DATA FROM PRIMARY SOURCES 21
2.2.3 ASSUMPTIONS FOR THE STUDY 21
3 EXECUTIVE SUMMARY 22
4 PREMIUM INSIGHTS 26
4.1 LUCRATIVE OPPORTUNITIES IN THE GLOBAL APTAMERS MARKET 26
4.2 LIFE CYCLE ANALYSIS, BY REGION (2015-2020) 28
5 MARKET OVERVIEW 29
5.1 INTRODUCTION 30
5.2 MARKET SEGMENTATION 30
5.2.1 BY TYPE 30
5.2.2 BY APPLICATION 30
5.2.3 BY TECHNOLOGY 31
5.2.4 BY END USER 31
5.3 MARKET DYNAMICS 32
5.3.1 DRIVERS 32
5.3.1.1 Strong trend of RandD investments in biotechnology and pharmaceutical companies 32
5.3.1.2 Technological advancements 33
5.3.1.3 Patent expiration of SELEX 33
5.3.1.4 Low-cost and high-efficiency as compared to antibodies 34
5.3.2 RESTRAINTS 35
5.3.2.1 Low market acceptance 35
5.3.2.2 Lack of trained professionals 36
5.3.3 OPPORTUNITIES 36
5.3.3.1 Applications in other industries 36
6 APTAMERS MARKET, BY TYPE 38
6.1 INTRODUCTION 39
6.2 DNA-BASED APTAMERS 40
6.3 RNA-BASED APTAMERS 42
6.4 XNA-BASED APTAMERS 45
7 APTAMERS MARKET, BY APPLICATION 48
7.1 INTRODUCTION 49
7.2 DIAGNOSTICS 50
7.3 THERAPEUTICS DEVELOPMENT 53
7.4 RESEARCH AND DEVELOPMENT 56
7.5 OTHER APPLICATIONS 58
8 APTAMERS MARKET, BY TECHNOLOGY 60
8.1 INTRODUCTION 61
8.2 SELEX 62
8.3 OTHER TECHNOLOGIES 64
9 APTAMERS MARKET, BY END USER 67
9.1 INTRODUCTION 68
9.2 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES 69
9.3 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 71
9.4 CONTRACT RESEARCH ORGANIZATIONS 73
9.5 OTHER END USERS 75
10 GLOBAL APTAMERS MARKET, BY REGION 77
10.1 INTRODUCTION 78
10.2 AMERICAS 80
10.2.1 U.S. 87
10.2.2 CANADA 89
10.2.3 LATIN AMERICA 90
10.3 EUROPE 93
10.4 ASIA 99
10.5 REST OF THE WORLD (ROW) 103

11 COMPETITIVE LANDSCAPE 107
11.1 INTRODUCTION 107
11.2 COMPETITIVE SITUATION AND TRENDS 107
11.2.1 AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS 108
11.2.2 CONTRACTS, DEVELOPMENT AGREEMENTS, FUNDING, GRANTS, AND REWARDS 109
11.2.3 NEW PRODUCT LAUNCHES 109
11.2.4 OTHER DEVELOPMENTS 110
12 COMPANY PROFILES 111
12.1 AM BIOTECHNOLOGIES, LLC 111
12.1.1 BUSINESS OVERVIEW 111
12.1.2 PRODUCT AND SERVICES 111
12.1.3 NEWS/EVENTS 112
12.2 APTAGEN, LLC 113
12.2.1 BUSINESS OVERVIEW 113
12.2.2 PRODUCT AND SERVICES 113
12.2.3 NEWS/EVENTS 113
12.3 APTAMER SCIENCES INC. 114
12.3.1 BUSINESS OVERVIEW 114
12.3.2 PRODUCT AND SERVICES 114
12.3.3 NEWS/EVENTS 115
12.4 APTAMER SOLUTIONS LTD. 116
12.4.1 BUSINESS OVERVIEW 116
12.4.2 PRODUCT AND SERVICES 116
12.4.3 NEWS/EVENTS 116
12.5 APTUS BIOTECH S.L. 117
12.5.1 BUSINESS OVERVIEW 117
12.5.2 PRODUCT AND SERVICES 117
12.5.3 NEWS/EVENTS 117
12.6 BASE PAIR BIOTECHNOLOGIES, INC. 119
12.6.1 BUSINESS OVERVIEW 119
12.6.2 PRODUCT AND SERVICES 119
12.6.3 NEWS/EVENTS 119
12.7 NEOVENTURES BIOTECHNOLOGY INC. 121
12.7.1 BUSINESS OVERVIEW 121
12.7.2 PRODUCT AND SERVICES 121
12.7.3 NEWS/EVENTS 121
12.8 SOMALOGIC, INC. 122
12.8.1 BUSINESS OVERVIEW 122
12.8.2 PRODUCT AND SERVICES 122
12.8.3 NEWS/EVENTS 122
12.9 TRILINK BIOTECHNOLOGIES, INC. 124
12.9.1 BUSINESS OVERVIEW 124
12.9.2 PRODUCT AND SERVICES 124
12.9.3 NEWS/EVENTS 124
12.10 VIVONICS, INC. 125
12.10.1 BUSINESS OVERVIEW 125
12.10.2 PRODUCT AND SERVICES 125
12.10.3 NEWS/EVENTS 125
13 APPENDIX 126
13.1 INSIGHTS OF INDUSTRY EXPERTS 126
13.2 DISCUSSION GUIDE 127
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 129
13.4 AVAILABLE CUSTOMIZATIONS 130
13.5 RELATED REPORTS 131


LIST OF TABLES

TABLE 1 APTAMERS MARKET SUMMARY 22
TABLE 2 INCREASING RandD INVESTMENTS BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES IS PROPELLING THE GROWTH OF THE APTAMERS MARKET 34
TABLE 3 LOW MARKET ACCEPTANCE OF APTAMERS AS COMPARED TO ANTIBODIES WOULD RESTRICT THE MARKET GROWTH 36
TABLE 4 APPLICATIONS IN OTHER INDUSTRIES PRESENT SIGNIFICANT GROWTH OPPORTUNITIES FOR THE APTAMERS MARKET 37
TABLE 5 APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 39
TABLE 6 DNA-BASED APTAMERS GENERATED AGAINST VARIOUS LIGANDS 40
TABLE 7 DNA-BASED APTAMERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 41
TABLE 8 AMERICAS: DNA-BASED APTAMERS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 42
TABLE 9 RNA-BASED APTAMERS GENERATED AGAINST VARIOUS LIGANDS 43
TABLE 10 RNA-BASED APTAMERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 44
TABLE 11 AMERICAS: RNA-BASED APTAMERS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 45
TABLE 12 COMMON CHEMICAL MODIFICATIONS OF APTAMERS FOR TUMOR TARGETING 46
TABLE 13 XNA-BASED APTAMERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 47
TABLE 14 AMERICAS: XNA-BASED APTAMERS MARKET SIZE, BY COUNTRY,
2013-2020 ($MILLION) 47
TABLE 15 APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 50
TABLE 16 LIST OF RNA APTAMER SEQUENCES AND THEIR TARGETS FOR TARGETED THERAPY AND THEIR DIAGNOSTIC APPLICATIONS 51
TABLE 17 APTAMERS MARKET SIZE FOR DIAGNOSTICS APPLICATION, BY REGION,
2013-2020 ($MILLION) 52
TABLE 18 THE AMERICAS: APTAMERS MARKET SIZE FOR DIAGNOSTICS, BY REGION,
2013-2020 ($MILLION) 53
TABLE 19 STATUS OF APTAMER THERAPEUTICS UNDERGOING CLINICAL TRAILS 54
TABLE 20 APTAMERS MARKET SIZE FOR THERAPEUTICS DEVELOPMENT APPLICATION,
BY REGION, 2013-2020 ($MILLION) 55
TABLE 21 AMERICAS: APTAMERS MARKET SIZE FOR THERAPEUTICS DEVELOPMENT,
BY REGION, 2013-2020 ($MILLION) 55
TABLE 22 APTAMERS MARKET SIZE FOR RESEARCH AND DEVELOPMENT, BY REGION, 2013-2020 ($MILLION) 57
TABLE 23 AMERICAS: APTAMERS MARKET SIZE FOR RESEARCH AND DEVELOPMENT,
BY REGION, 2013-2020 ($MILLION) 57
TABLE 24 APTAMERS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION,
2013-2020 ($MILLION) 59
TABLE 25 AMERICAS: APTAMERS MARKET SIZE FOR OTHER APPLICATIONS, BY REGION, 2013-2020 ($MILLION) 59
TABLE 26 APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION) 61
TABLE 27 LIST OF MODIFICATIONS TO THE SELEX PROCESS AND THEIR DESCRIPTIONS 62
TABLE 28 APTAMERS MARKET SIZE FOR SELEX, BY REGION, 2013-2020 ($MILLION) 63
TABLE 29 AMERICAS: APTAMERS MARKET SIZE FOR SELEX, BY REGION,
2013-2020 ($MILLION) 64
TABLE 30 APTAMERS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION,
2013-2020 ($MILLION) 65
TABLE 31 AMERICAS: APTAMERS MARKET SIZE FOR OTHER TECHNOLOGIES, BY REGION, 2013-2020 ($MILLION) 66
TABLE 32 APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 69
TABLE 33 APTAMERS MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2013-2020 ($MILLION) 70
TABLE 34 AMERICAS: APTAMERS MARKET SIZE FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES, BY COUNTRY, 2013-2020 ($MILLION) 71
TABLE 35 APTAMERS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY REGION, 2013-2020 ($MILLION) 72
TABLE 36 AMERICAS: APTAMERS MARKET SIZE FOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY COUNTRY, 2013-2020 ($MILLION) 73
TABLE 37 APTAMERS MARKET SIZE FOR CROS, BY REGION, 2013-2020 ($MILLION) 74
TABLE 38 AMERICAS: APTAMERS MARKET SIZE FOR CROS, BY COUNTRY,
2013-2020 ($MILLION) 74
TABLE 39 APTAMERS MARKET SIZE FOR OTHER END USERS, BY REGION,
2013-2020 ($MILLION) 76
TABLE 40 AMERICAS: APTAMERS MARKET SIZE FOR OTHER END USERS, BY COUNTRY, 2013-2020 ($MILLION) 76
TABLE 41 APTAMERS MARKET SIZE, BY REGION, 2013-2020 ($MILLION) 79
TABLE 42 AMERICAS: APTAMERS MARKET SIZE, BY COUNTRY, 2013-2020 ($MILLION) 82
TABLE 43 AMERICAS: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 83
TABLE 44 AMERICAS: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 84
TABLE 45 AMERICAS: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION) 85
TABLE 46 AMERICAS: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 86
TABLE 47 U.S.: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 87
TABLE 48 U.S.: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 88
TABLE 49 U.S.: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION) 88
TABLE 50 U.S.: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 88
TABLE 51 CANADA: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 89
TABLE 52 CANADA: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 89
TABLE 53 CANADA: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION) 90
TABLE 54 CANADA: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 90
TABLE 55 LATIN AMERICA: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 91
TABLE 56 LATIN AMERICA: APTAMERS MARKET SIZE, BY APPLICATION,
2013-2020 ($MILLION) 91
TABLE 57 LATIN AMERICA: APTAMERS MARKET SIZE, BY TECHNOLOGY,
2013-2020 ($MILLION) 92
TABLE 58 LATIN AMERICA: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 92
TABLE 59 EUROPE: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 95
TABLE 60 EUROPE: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 96
TABLE 61 EUROPE: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION) 97
TABLE 62 EUROPE: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 98
TABLE 63 ASIA: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 100
TABLE 64 ASIA: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 100
TABLE 65 ASIA: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION) 101
TABLE 66 ASIA: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 102
TABLE 67 ROW: APTAMERS MARKET SIZE, BY TYPE, 2013-2020 ($MILLION) 104
TABLE 68 ROW: APTAMERS MARKET SIZE, BY APPLICATION, 2013-2020 ($MILLION) 104
TABLE 69 ROW: APTAMERS MARKET SIZE, BY TECHNOLOGY, 2013-2020 ($MILLION) 105
TABLE 70 ROW: APTAMERS MARKET SIZE, BY END USER, 2013-2020 ($MILLION) 106
TABLE 71 AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS,
2011-2015 108
TABLE 72 CONTRACTS, DEVELOPMENT AGREEMENTS, FUNDING, GRANTS, AND REWARDS, 2011-2015 109
TABLE 73 NEW PRODUCT LAUNCHES, 2011-2015 110
TABLE 74 OTHER DEVELOPMENTS, 2011-2015 110


LIST OF FIGURES

FIGURE 1 APTAMERS MARKET 15
FIGURE 2 RESEARCH DESIGN 17
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 18
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 19
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY DESIGNATION AND REGION 19
FIGURE 6 DATA TRIANGULATION METHODOLOGY 20
FIGURE 7 APTAMERS MARKET SIZE, BY TYPE, 2015 VS. 2020 ($MILLION) 23
FIGURE 8 APTAMERS MARKET SIZE, BY APPLICATION, 2015 VS. 2020 ($MILLION) 23
FIGURE 9 APTAMERS MARKET SIZE, BY TECHNOLOGY, 2015 VS. 2020 ($MILLION) 24
FIGURE 10 APTAMERS MARKET SIZE, BY END USER, 2015 VS. 2020 ($MILLION) 24
FIGURE 11 APTAMERS MARKET SIZE, BY REGION, 2015 VS. 2020 ($MILLION) 25
FIGURE 12 GLOBAL APTAMERS MARKET TO WITNESS HIGH GROWTH DURING THE FORECAST PERIOD 26
FIGURE 13 DIAGNOSTICS APPLICATIONS TO ACCOUNT FOR THE LARGEST MARKET SHARE
IN 2015 26
FIGURE 14 EUROPE TO WITNESS HIGHEST GROWTH RATE FROM 2015 TO 2020 27
FIGURE 15 EUROPEAN MARKET SHOWCASES LUCRATIVE GROWTH OPPORTUNITIES 28
FIGURE 16 APTAMERS MARKET SEGMENTATION: BY TYPE 30
FIGURE 17 APTAMERS MARKET SEGMENTATION: BY APPLICATION 30
FIGURE 18 APTAMERS MARKET SEGMENTATION: TECHNOLOGY 31
FIGURE 19 APTAMERS MARKET SEGMENTATION: BY END USER 31
FIGURE 20 STRONG TREND OF RandD INVESTMENTS BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES WILL DRIVE THE APTAMERS MARKET 32
FIGURE 21 NEW PHARMACEUTICAL DRUG LAUNCHES (2003-2013) 33
FIGURE 22 APTAMERS MARKET SEGMENTATION, BY TYPE 39
FIGURE 23 DNA-BASED APTAMERS SEGMENT COMMAND THE LARGEST SHARE OF THE APTAMERS MARKET, 2015 ($MILLION) 39
FIGURE 24 THE AMERICAS TO COMMAND THE LARGEST SHARE OF THE DNA-BASED APTAMERS MARKET BY 2020 41
FIGURE 25 THE AMERICAS TO COMMAND THE LARGEST SHARE OF THE RNA-BASED APTAMERS MARKET IN 2015 44
FIGURE 26 EUROPE TO BE THE LARGEST AND FASTEST-GROWING REGIONAL SEGMENT OF THE XNA-BASED APTAMERS MARKET BY 2020 46
FIGURE 27 APTAMERS MARKET, BY APPLICATION 49
FIGURE 28 DIAGNOSTICS APPLICATION SEGMENT COMMANDS THE LARGEST SHARE OF THE APTAMERS MARKET IN 2015 ($MILLION) 49
FIGURE 29 EUROPE, THE FASTEST-GROWING REGIONAL SEGMENT FOR DIAGNOSTICS APPLICATIONS, 2015 VS. 2020 ($MILLION) 52
FIGURE 30 AMERICAS EXPECTED TO BE THE LARGEST REGIONAL SEGMENT FOR THERAPEUTICS DEVELOPMENT APPLICATION ($MILLION) 54
FIGURE 31 AMERICAS TO DOMINATE THE RandD APPLICATION SEGMENT IN 2015 56
FIGURE 32 EUROPEAN OTHER APPLICATIONS SEGMENT TO WITNESS FASTEST GROWTH 58
FIGURE 33 APTAMERS MARKET SEGMENTATION, BY TECHNOLOGY 61
FIGURE 34 APTAMERS MARKET, BY TECHNOLOGY, 2015 VS. 2020 ($MILLION) 61
FIGURE 35 AMERICAS TO COMMAND THE LARGEST SHARE OF THE SELEX SEGMENT BY 2020 63
FIGURE 36 EUROPE WILL BE THE FASTEST-GROWING REGIONAL SEGMENT FOR OTHER TECHNOLOGIES IN 2020 65
FIGURE 37 APTAMERS MARKET SEGMENTATION, BY END USER 68
FIGURE 38 APTAMERS MARKET SIZE, BY END USER, 2015 VS. 2020 ($MILLION) 68
FIGURE 39 PUBLIC-SECTOR RESEARCH FUNDING IS DRIVING THE GROWTH OF THE ACADEMIC and GOVERNMENT RESEARCH INSTITUTES MARKET 69
FIGURE 40 THE AMERICAS DOMINATE THE APTAMERS MARKET FOR ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES 70
FIGURE 41 NUMBER OF BIOTECHNOLOGY AND PHARMACEUTICAL PATENTS GRANTED IN 2012, BY REGION 71
FIGURE 42 BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES SEGMENT TO WITNESS THE HIGHEST GROWTH IN EUROPE 72
FIGURE 43 THE AMERICAS ARE EXPECTED TO DOMINATE THE APTAMERS MARKET FOR CROS 74
FIGURE 44 EUROPE TO WITNESS HIGHEST GROWTH IN THE APTAMERS MARKET FOR OTHER END USERS IN THE FORECAST PERIOD 75
FIGURE 45 APTAMERS MARKET SEGMENTATION, BY REGION 78
FIGURE 46 AMERICAS TO DOMINATE THE GLOBAL APTAMERS MARKET 78
FIGURE 47 APTAMERS MARKET IN EUROPE TO WITNESS THE HIGHEST GROWTH FROM 2015 TO 2020 79
FIGURE 48 AMERICAS: MARKET SNAPSHOT 81
FIGURE 49 U.S. TO DOMINATE THE APTAMERS MARKET IN THE AMERICAS 82
FIGURE 50 DNA-BASED APTAMERS TO COMMAND THE LARGEST SHARE OF THE APTAMERS MARKET IN THE AMERICAS 83
FIGURE 51 DIAGNOSTICS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS APPLICATIONS MARKET IN AMERICAS 84
FIGURE 52 SELEX FORMED THE LARGEST TECHNOLOGY SEGMENT IN THE AMERICAS 85
FIGURE 53 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES FORMED THE LARGEST END-USER SEGMENT IN THE AMERICAS 86
FIGURE 54 EUROPE: MARKET SNAPSHOT 94
FIGURE 55 DNA-BASED APTAMERS TO COMMAND THE LARGEST SHARE OF THE EUROPEAN APTAMERS MARKET 95
FIGURE 56 DIAGNOSTICS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS APPLICATIONS MARKET IN EUROPE 96
FIGURE 57 SELEX FORMED THE LARGEST TECHNOLOGY SEGMENT IN EUROPE 97
FIGURE 58 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS END-USERS MARKET IN EUROPE 98
FIGURE 59 DNA-BASED APTAMERS TO COMMAND THE LARGEST SHARE OF THE APTAMERS MARKET IN ASIA 99
FIGURE 60 DIAGNOSTICS APPLICATION SEGMENT TO DOMINATE THE APTAMERS MARKET
IN ASIA 100
FIGURE 61 SELEX SEGMENT TO ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS TECHNOLOGIES MARKET IN ASIA 101
FIGURE 62 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES TO ACCOUNT FOR THE LARGEST SHARE OF THE APTAMERS END-USER MARKET IN ASIA 102
FIGURE 63 DNA-BASED APTAMERS TO COMMAND THE LARGEST SHARE OF THE ROW APTAMERS MARKET 103
FIGURE 64 THE DIAGNOSTICS APPLICATION SEGMENT TO COMMAND THE LARGEST SHARE OF THE APTAMERS MARKET IN THE ROW REGION 104
FIGURE 65 THE SELEX TECHNOLOGY SEGMENT IS EXPECTED TO DOMINATE THE ROW APTAMERS MARKET IN 2015 105
FIGURE 66 ACADEMIC AND GOVERNMENT RESEARCH INSTITUTES SEGMENT TO DOMINATE THE ROW MARKET FOR APTAMERS 106
FIGURE 67 GROWTH STRATEGIES: AGREEMENTS, COLLABORATIONS, EXPANSIONS, AND PARTNERSHIPS WAS THE KEY STRATEGY 107

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
White Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

White Biotechnology Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

  • $ 5795
  • Industry report
  • August 2016
  • by Transparency Market Research

This report on the white biotechnology market studies the current as well as future prospects of the market globally. Environment concerns related to emission of greenhouse gases and dependence on non-renewable ...

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

Bioinformatics Market by Sector (Molecular Medicine, Agriculture, Forensic, Animal, Research & Gene Therapy), Product (Sequencing Platforms, Knowledge Management & Data Analysis) & Application (Genomics, Proteomics & Metabolomics) - Global Forecast to 202

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global bioinformatics market is projected to reach USD 16.18 billion by 2021 from USD 6.21 billion in 2016, growing at a CAGR of 21.1% during the forecast period. In this report, the bioinformatics ...

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

Molecular Biology Enzymes and Kits & Reagents Market by Product, Application, End User - Trends & Global Forecasts to 2021

  • $ 5650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The molecular biology enzymes and kits & reagents market is projected to reach USD 12.69 billion by 2021 from USD 5.77 billion in 2016, growing at a CAGR of 17.1% during the forecast period of 2016 to ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.